<SEC-DOCUMENT>0001213900-20-001797.txt : 20200127
<SEC-HEADER>0001213900-20-001797.hdr.sgml : 20200127
<ACCEPTANCE-DATETIME>20200124184652
ACCESSION NUMBER:		0001213900-20-001797
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20200127
DATE AS OF CHANGE:		20200124

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AYTU BIOSCIENCE, INC
		CENTRAL INDEX KEY:			0001385818
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				470883144
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-235695
		FILM NUMBER:		20546765

	BUSINESS ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 206
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		(720) 437-6580

	MAIL ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 206
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AYTU BIOSCIENCE, INC.
		DATE OF NAME CHANGE:	20150609

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Rosewind CORP
		DATE OF NAME CHANGE:	20070110
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>f424b3012420_aytubiosci.htm
<DESCRIPTION>PROSPECTUS SUPPLEMENT NO. 2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Prospectus Supplement No. 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed Pursuant to Rule 424(b)(3)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>File No. 333-235695</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="image_001.jpg" ALT="" STYLE="height: 77px; width: 242px"></FONT></TD>
    <TD STYLE="width: 50%; text-align: right; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 45px; width: 211px">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Prospectus Supplement No. 2 Dated January
24, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">To Prospectus Dated January 15, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus supplement No.2 supplements
the prospectus dated January 15, 2020 relating to the offering and sale by Aytu BioScience, Inc. (&ldquo;Aytu&rdquo;) of shares
of its common stock relating to the potential merger with Innovus Pharmaceuticals, Inc. This prospectus supplement should be read
in conjunction with the prospectus which is to be delivered with this prospectus supplement. Any statement contained in the prospectus
shall be deemed to be modified or superseded to the extent that information in this prospectus supplement modifies or supersedes
such statement. Any statement that is modified or superseded shall not be deemed to constitute a part of the prospectus except
as modified or superseded by this prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus supplement
is being filed to update and supplement the information in the prospectus with our Current Report on Form 8-K filed with the Securities
and Exchange Commission on January 24, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Investing in our common stock involves
a high degree of risk. Before making an investment decision, please read &ldquo;Risk Factors&rdquo; beginning on page 26 of this
prospectus. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of the securities to be issued in connection with the transaction
described in the Prospectus or determined whether the Prospectus is truthful or complete. Any representation to the contrary is
a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">This date of this prospectus
supplement is January 24, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):&nbsp;&nbsp;<B>January
24, 2020</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AYTU BIOSCIENCE, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 7.5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="width: 34%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>001-38247</B></FONT></TD>
    <TD STYLE="width: 33%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>47-0883144</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction of incorporation)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission File Number)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>373 Inverness Parkway, Suite 206</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Englewood, CO 80112</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices,
including Zip Code)</P>

<P STYLE="font: 7.5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&rsquo;s telephone number, including
area code: <B>(720) 437-6580</B></P>

<P STYLE="font: 7.5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>N/A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed
since last report)</P>

<P STYLE="font: 7.5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form&nbsp;8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 7.5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD STYLE="text-align: justify">Written communications pursuant to Rule&nbsp;425 under
the Securities Act (17 CFR 230.425)</TD>
</TR></TABLE>

<P STYLE="font: 7.5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD STYLE="text-align: justify">Soliciting material pursuant to Rule&nbsp;14a-12 under
the Exchange Act (17 CFR 240.14a-12)</TD>
</TR></TABLE>

<P STYLE="font: 7.5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))</TD>
</TR></TABLE>

<P STYLE="font: 7.5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))</TD>
</TR></TABLE>

<P STYLE="font: 7.5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section
12(b) of the Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title of each class</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trading Symbol(s)</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name of each exchange on which registered</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock, par value $0.0001 per share</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AYTU</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The NASDAQ Stock Market LLC</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: -0.25in">Emerging growth company
&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 5.07 Submission of Matters to a Vote of Security Holders.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The special meeting of stockholders for Aytu BioScience, Inc.
(the &ldquo;Company&rdquo;) was held on January 24, 2020. Of the 20,733,052 shares outstanding on the record date for the meeting,
a total of 16,679,856 shares were present or represented at the meeting. <FONT STYLE="background-color: white">The matters voted
on as described in the Company&rsquo;s definitive proxy statement, as filed on December 23, 2019, and the results of the votes
are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">The &ldquo;Nasdaq Rule 5635(d) Proposal&rdquo; described
in the Company&rsquo;s definitive proxy statement was approved with 9,173,191 votes in favor, 267,716 votes against and 55,392
abstentions. The number of broker non-votes was 7,183,557.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify">The &ldquo;Conversion Proposal&rdquo; described in the
Company&rsquo;s definitive proxy statement was approved with 9,183,745 votes in favor, 268,340 votes against and 44,214 abstentions.
The number of broker non-votes was 7,183,557.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">3.</TD><TD STYLE="text-align: justify">The &ldquo;Authorized Share Increase Proposal&rdquo; described
in the Company&rsquo;s definitive proxy statement was approved with 14,853,035 votes in favor, 1,755,451 votes against and 71,370
abstentions.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">4.</TD><TD STYLE="text-align: justify">The proposal to approve the adjournment of the Special
Meeting, if necessary, to continue to solicit votes for the Nasdaq Rule 5635(d) Proposal and/or the Authorized Share Increase
Proposal&nbsp;was approved with 14,984,656 votes in favor, 1,579,227 votes against and 115,973 abstentions.</TD>
</TR></TABLE>

<P STYLE="font: 7.5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AYTU BIOSCIENCE, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 34%">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 24, 2019</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Joshua R. Disbrow</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joshua R. Disbrow</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !- /(# 2(  A$! Q$!_\0
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M:UL5Y/X?^-/@;3_#>E6=QJDJSV]G#%(HM93AE0 C.WU%:/\ PO3P!_T%IO\
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M3K.PLH+.VMHX[>"-8HD X55& /R%%6J* "BBB@ HHHH **** "BBB@ HHHH
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G'##.!QVI@=3:RM/:0S/&8WDC5F0C!4D9Q14JY"C<<G')QUHI ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  M -,# 2(  A$! Q$!_\0
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M"_C7,MN3_P"/+ZK_ "[]L[8G!2HKF3NOR,,-CHUGRM6?YG2T5P/Q< /A>R!
M(^WKU_ZYR5M> ACP-I8''[ML?]]-6+HVHJK?=V-U6O6=*VRN3>*/$5CH6GLD
M^HQ65W<1NMJ[QM( ^.&(4'@$C/:J-[>>(+?3M,\J9;J1X09KBUA#+*_'08.
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MP/;V]:*TEC\-=^Y?Y(SC@,39>_;YLZRBBBO&/:"BBB@ HHHH **** "BBB@
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F$U2\59#M6>0#=ECC<>I)R?J:*\V688M-K3[D>G'+L)))Z_>S_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
